Everything Gold (blog) | Arena Charges On Motley Fool It seems Fool readers were a little more optimistic about the timing of Arena Pharmaceuticals' (Nasdaq: ARNA) resubmission ... Arena F » |
Wednesday, December 22, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment